Hasan Abdulkarim, Deyab Abdou, Monazea Khaled, Salem Abdoh, Futooh Zahraa, Mostafa Mahmoud A, Youssef Ahmed, Nasr Mohamed, Omar Nasser, Rabaan Ali A, Taie Doha M
Department of Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Department of Obstetrics and Gynecology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Ann Med Surg (Lond). 2021 Jan 21;62:219-224. doi: 10.1016/j.amsu.2021.01.029. eCollection 2021 Feb.
Over the past few decades, the rate of Cesarean Section (CS) delivery has been rising rapidly and the prevalence of CS-associated complications including Abdominal Wall Endometriomas (AWE) increases with each additional operation. The aim of this study was to evaluate the clinical characteristics, histopathological diagnostic role and surgical management of post-CS AWE through a retrospective case review.
We calculated the incidence of AWE and reviewed all the patients underwent surgical removal of Post-CS AWE during the period of 2012-2018 who were diagnosed, treated and followed up for 2-8 years at our tertiary hospital.
Thirty women with AWE were included. The main symptom in 2/3 of cases was cyclic pain and 4 cases (13.3%) had no symptoms. The mean interval between prior CS and appearance of symptoms was 55.2 months and the mean size of the excised mass was 42 mm. Free surgical margin was less than 9 mm in 9 patients (30%) but no recurrence was recorded among all the studied patients. Pre-operative FNAC diagnosis was performed for only 3 patients (10%) which helped in excluding other potential pathologies. The clinical-pathological agreement value for detection of the nature of the abdominal wall mass was 93.4%.
Patients with suspected AWE should undergo preoperative cytological biopsy to exclude alternative diagnosis. Wide surgical excision with margin of less than 1 cm could be accepted especially in case of weak abdominal wall. More studies on the post-CS complications; risks, prevention, early detection and proper management should be encouraged.
在过去几十年中,剖宫产(CS)分娩率迅速上升,包括腹壁子宫内膜异位症(AWE)在内的CS相关并发症的发生率随着手术次数的增加而上升。本研究的目的是通过回顾性病例分析来评估CS术后AWE的临床特征、组织病理学诊断作用及手术治疗方法。
我们计算了AWE的发病率,并回顾了2012年至2018年期间在我院接受手术切除CS术后AWE的所有患者,这些患者均在我院接受了诊断、治疗及2至8年的随访。
纳入了30例AWE患者。2/3的病例主要症状为周期性疼痛,4例(13.3%)无症状。上次剖宫产与症状出现之间的平均间隔为55.2个月,切除肿块的平均大小为42mm。9例患者(30%)手术切缘小于9mm,但所有研究患者均未记录到复发情况。仅3例患者(10%)进行了术前细针穿刺抽吸活检(FNAC),这有助于排除其他潜在病变。腹壁肿块性质检测的临床病理符合率为93.4%。
疑似AWE的患者应接受术前细胞学活检以排除其他诊断。特别是在腹壁薄弱的情况下,可接受切缘小于1cm的广泛手术切除。应鼓励对CS术后并发症进行更多研究,包括风险、预防、早期检测和适当管理。